» Articles » PMID: 39735594

A Preliminary Study on Transcriptional Regulation of SNP Site C-1888T in the Promoter Region of Human PLUNC Gene and Nasopharyngeal Carcinoma Susceptibility

Overview
Specialty Genetics
Date 2024 Dec 30
PMID 39735594
Authors
Affiliations
Soon will be listed here.
Abstract

The transcriptional regulatory factors binding to the polymorphic site C-1888T in the promoter region of the palate, lung, and nasal epithelium clone (PLUNC) gene were identified to investigate whether the C-1888T polymorphic site affects the transcriptional regulation and function of PLUNC gene. Three genotypes of C-1888T polymorphic locus were screened from established nasopharyngeal carcinoma (NPC) cells, and the mRNA expression levels of PLUNC gene in different genotypes were detected. The respective transcription factors that were more likely to bind with A or G in SNP were predicted by biological information and preliminarily verified in vitro by gel electrophoresis migration rate analysis. Ulteriorly, the NPC cell lines were analyzed through chromatin immunoprecipitation combined with PCR amplification to confirm that the transcription factors could bind to the PLUNC gene promoter. The cell lines 5-8F, 6-10B, CNE1, and CNE2 were heterozygous CT type, SUNE1 was homozygous CC type, and C666-1 was homozygous TT type. The expression of PLUNC gene was significantly different among all cell lines ( = 33.844, < 0.001), and the gene expression level of CC type was significantly lower than TT type ( < 0.001). Gel electrophoresis mobility analysis confirmed that the transcription factors XFD3 and EVI1 could bind to the PLUNC gene promoter when the SNP was A and G, respectively. PCR amplification combined with chromatin immunoprecipitation showed that EVI1 could bind to the DNA fragment of the promoter region of PLUNC gene in SUNE1 NPC cells. The transcription factors XFD3 and EVI1 may be involved in the transcriptional regulation of PLUNC gene, and EVI1 can bind to the promoter region of PLUNC gene in SUNE1 NPC cells, thus associated with the susceptibility/risk of NPC.

References
1.
Zhu C, Wang J, Shi B, Hu P, Ning B, Zhang Q . The transcription factor FOXA2 suppresses gastric tumorigenesis in vitro and in vivo. Dig Dis Sci. 2014; 60(1):109-17. DOI: 10.1007/s10620-014-3290-4. View

2.
Zhang B, Nie X, Xiao B, Xiang J, Shen S, Gong J . Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer. 2003; 38(1):80-90. DOI: 10.1002/gcc.10247. View

3.
Lu Y, Liang Y, Zheng X, Deng X, Huang W, Zhang G . EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2019; 38(1):82. PMC: 6377731. DOI: 10.1186/s13046-019-1077-3. View

4.
Paredes-Duran L, Del Barco-Morillo E, Baldeon-Conde M, Medina-Valdivieso S, Guillen-Sacoto M, Cruz-Hernandez J . Familial clustering of nasopharyngeal carcinoma in non-endemic area. Report of three families. Acta Otorrinolaringol Esp (Engl Ed). 2016; 68(3):164-168. DOI: 10.1016/j.otorri.2016.07.006. View

5.
Kaestner K . The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol Metab. 2000; 11(7):281-5. DOI: 10.1016/s1043-2760(00)00271-x. View